게르마늄 강화효모의 마우스에서의 암세포 억제 및대식세포, NK 세포, B 세포의 활성화에 관한 연구

참고문헌 (29)

1. Watanabe, "Effect of Ge-132 products and related synthetic compounds", pp.1 536~539 (1981)
2. Suzuki, "Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge- 132", immu(l), pp.2 65~74 (1985)
3. Badawi, A. M, "Synthesis and immunomodulatory activity of some novel amino acid germinates", 4, pp.107~113 (2007)
4. Bigitta, E. L, "Renal and other organ failure caused by germanium intoxication", 14, pp.2464~2468 (1999)
5. 5 Faubert,G.M, "Depression of the plaque-forming cells to sheep red blood cells by the new-born larvae of Trichinella spiralis", 30, pp.485~489 (1976)
6. D′Onofrio, "Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia", pp.6 385~395 (1990)
7. Ohashi, "Multidisciplinary treatment of head and neck cancer using BCG and GE-132 as biologic response modifiers", pp.7 30~432 38 (1994)
8. 9 Goodman, "Therapeutic effects of organic germanium", pp.207~215 (1988)
9. Joo, S. S, "Effect of Geranti Bio-Ge yeast, a dried yeast containing biogermanium, on the production of antibodies by B cells", 6, pp.86~92 (2006)
10. Lee, J. H, "Anti-inflammatory effect of germaniumconcentrated yeast against paw oedema is related to the inhibition of arachidonic acid release and prostaglandin E2 production in RBL 2H3 cells", 25, pp.129~134 (2005)
11. Lee, J. S, "ral single-and repeated-dose oxicity studies on Geranti Bio-Ge yeast, organic germanium fortified yeasts, in rats", 29, pp.541~553 (2004)
12. Lee, J. S, "Oral single-and repeated-dose oxicity studies on Geranti Bio-Ge yeast, organic germanium fortified yeasts, in dogs", 29, pp.555~569 (2004)
13. Lee, S. H, "Oral repeated-dose toxicity studies especially in the liver and kidney of rats administered with organic germanium-fortified yeasts", 11, pp.115~119 (2006)
14. Lee, S. H, "Efficacy study of activation on macrophage in germanium-fortified yeast", 48, pp.246~251 (2005)
15. Lee, S. H, "Effects of germanium-fortified yeast on the serum lipids and immune cell subset", 35, pp.1~7 (2006)
16. Arai, "Induction of interferon production by NK cells by organogermanium compound", kuwa, pp.17 69~132 76 (1987)
17. I, "New approaches to using spent brewer’s yeast", 18(bohiro), pp.5~8 (1980)
18. 19 Okada, "Renal railure caused by long-term use of a germanium preparation as an elixir", pp.219~224 (1989)
19. A, "Dual role for alveolar macrophages in humoral and cell-mediated immune response evidence for suppressor and enhancing functions", pp.20 205~217 (1981)
20. U, "Cytoadherence characteristics of rosette-forming Plasmodium falciparum", pp.21 4483~4490 (1992)
21. 22 Schauss,A.G, "Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide", 29, pp.267~280 (1991)
22. 23 Sohn, "Process for preparing S"
23. 24 Suzuki, "Suppression of tumor growth by isolated peritoneal macrophages from mice treated with carboxyethylgermanium sesquioxide", pp.2122~132 2128 (1985)
24. 25 Suzuki, "Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide", pp.479~132 483 (1985)
25. 26 Suzuki, "Cooperation of lymphokines and macrophages in expression of antitumor activity of carboxyehtylgermanium sesquioxide", pp.177~132 182 (1986)
26. 27 Swenson, "Phagocytosis of Cryptococcus neoformans by normal and thioglycolateactivated macrophages", pp.714~720 (1978)
27. Tao, S. H., "Hazard assessment of germanium supplements", Regulatory Toxicology and Pharmacology, pp.25~ (1997), 211
28. I, "Increased oxygen species generation in blood monocytes of asthmatic patients", pp.29 1161~1166 (1992)
29. 30 Wright, "Tumor promoting phorbol ester stimulated C3b and C3b’ receptor-mediated phagocytosis in cultured human monocytes", pp.1149~1162 (1982)

관련 논문AI추천